Call for Papers

  • Home
  • Call for Papers

Results of ISA2021 Moderated Session and Poster

Thank you for submitting your abstract to ISA2021.
We have reviewed all submitted abstracts carefully and we are now pleased to announce the results.
We sent the notification on Sep 10, and please contact congress secretariat ( if you’ve not received the email.

Results of APSAVD Oral and Poster

Thank you for submitting your abstract to APSAVD.
We sent the notification on Sep 26, and please contact congress secretariat ( if you’ve not received the email.

APSAVD judges have evaluated presentations at oral and poster sessions and selected winners.

ISA2021 Young Investigator's Award

ISA2021 YIA Selection Committee

Yasufumi Sato
(Tohoku University, Japan)
Shizuya Yamashita
(Rinku General Medical Center, Japan)
Masayuki Yoshida
(Tokyo Medical and Dental University, Japan)
Yujiro Asada
(University of Miyazaki, Japan)
Raul Santos
(The University of São Paulo Medical School, Brazil)
Peter Libby
(Brigham and Women's Hospital, Harvard Medical School, USA)
Samia Mora
(Brigham and Women's Hospital, Harvard Medical School, USA)

International Atherosclerosis Society (IAS) Regional Federation for Asia Pacific (AP) Young Investigator's Grant

ISA2021 & APSAVD Submission Guidelines

Please note if you submit your abstract under APSAVD, it will not be reviewed for any ISA 2021 and IAS AP Young Investigator Awards. You will not be able to submit the same abstracts to both organizations.

ISA2021 invites your submission for papers to be presented at ISA2021 held in Hybrid Format (On-site in Kyoto, and online subscription) from October 24 – 27, 2021 (On-site, including live sessions) and until November 30, 2021 for on-demand subscription.

You’re also invited to submit your abstract to the Asian-Pacific Society of Atherosclerosis and Vascular Diseases and have your abstract reviewed by the APSAVD committee for consideration of prizes.
Please check the details about APSAVD prizes.

Please check the submission guidelines and follow the instructions.

  • Abstracts must be submitted online only, through the designated submission site.
  • Abstracts must be written in English.
  • All submissions will be peer reviewed. The Organizing Committee has the right to make the final decision on all submissions.
  • Abstracts that are accepted must be presented by the pre-registered author.
  • The abstracts will be published in the Online Abstract. exactly as submitted.
  • The body of the abstract should not exceed 350 words in English.
  • The title of the abstract should not exceed 40 words in English.
  • Up to 2 supporting files (i.e. images, graphs, tables) can accompany the abstract body.
  • Accepted submitters are required to complete their registration and payment within 2 weeks of notification of acceptance. Those who failed to register by the designated date will not be included in the program.

ISA2021 Abstract

  • Late-Breaking Abstracts can be submitted until July 30 noon (JST).
  • Abstracts are to be submitted for poster presentation. Some distinguished papers will be selected to present at oral sessions.
  • Poster presentations will also be organized in a hybrid format. Detailed instruction will be announced by the end of August.

APSAVD Abstract

  • Abstracts can be until August 10, 2021.
  • APSAVD will run oral sessions for award finalists. Highly ranked abstracts will be eligible to become a finalist in these sessions. Each finalist will submit a pre-recorded presentation for 10 minutes followed by 5 minutes Q&A through the online portal. APSAVD judges will evaluate these finalist presentations and select winners as appropriate. Winners and runner up prizes of $500USD and $300USD respectively will be available.


Dyslipidemia Lipids, lipoproteins and apolipoproteins
Pathogenesis Endothelium, macrophages, smooth muscle cells, thrombosis, inflammation, immunity, microbiome
Epidemiology Risk factors, add obesity and diabetes, population health, vulnerable communities, children and adolescents
Prevention Lifestyle measures and pharmacological intervention
Therapeutics Pharmacologic intervention, new treatment modalities, late breaking clinical trials


  • Basic science
  • Clinical aspects of CVD
  • Clinical studies
  • COVID-19
  • Diabetes and new therapies
  • Endothelium
  • Epidemiology of CVD and risk stratification
  • Evidence-based lifestyle intervention
  • Familial hypercholesterolemia and LDL
  • Genetics
  • Guidelines updates
  • HDL function
  • Imaging and atherosclerosis
  • Imaging of CVD
  • Inflammation and the immune system
  • Lipoprotein metabolism
  • Macrophages
  • Metabolic Syndrome
  • NASH
  • Nutrition and lifestyle
  • Pathogenesis of atherosclerosis
  • PCSK9
  • Pharmacology of CVD
  • Reverse cholesterol transport
  • Thrombosis
  • Triglyceride-rich lipoproteins and non-HDL
  • Others

Submission Procedure

  1. Access the ISA2021 or APSAVD Submission Page, and create your account first.
  2. Enter necessary information and abstract body by following the instruction given on the submission page, and submit.
  3. After you submit your paper, no changes or udpates will be accepted.

**Please note that if you submit your abstract to APSAVD, your abstract will not be reviewed for any ISA 2021 and IAS AP Young Investigator Awards. You will not be able to submit abstracts to both ISA2021 and APSAVD.